300 cirrhosis patients join study to uncover hidden triggers of liver cancer

NCT ID NCT07119957

Recruiting now Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting blood, urine, and stool samples from 300 people with cirrhosis to build a biobank. Researchers will later use these samples to understand how factors like nutrition, physical activity, smoking, alcohol, and pollution influence the development of the most common type of liver cancer (HCC). The goal is to identify what pushes some cirrhosis patients toward cancer, which remains largely unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA LIVER CIRRHOSES, LIVER

Contacts and locations

Locations

Angers University Hospital
RECRUITING

Angers, 49000, France
Centre Eugène Marquis (Oncology center)
NOT_YET_RECRUITING

Rennes, 35000, France
Rennes University Hospital, Hepatogastroenteroly Department
NOT_YET_RECRUITING

Rennes, 35000, France
Tours University Hospital, HepatoGastroenterology Department
NOT_YET_RECRUITING

Tours, 37170, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.